Printer Friendly

Five-kilometers time trial: preliminary validation of a short test for cycling performance evaluation.

1. Background

The professional cycling schedule (training and competition) limits the available time for physical fitness assessment (1). Consequently, tests should have short exercise duration, lower exercise-induced fatigue, provide relevant information, and resemble the real competition to motivate high performance of the athletes (2, 3). Thus, good tests should balance the vectors of feasibility, reliability, ecological validity (3), and sensitivity to detect the small and specific physiological adaptations to high-level training (2). Incremental test on cycle simulator is the most common protocol to evaluate cardiorespiratory fitness of endurance athletes (4). Although such test provides important aerobic endurance indices (e.g. maximal aerobic power output and aerobic and anaerobic thresholds), it has low ecological validity regarding the specific aerobic endurance performance of the sport. On the other hand, time trial has been indicated as the most reliable and ecologically valid protocol to assess this specific performance, to predict the competitive performance and to track the effects of training interventions on aerobic endurance of road cyclists (2, 5). This test consists of cycling a predetermined distance as fast as possible, in self-selected pace. Time trial resembles real competition rather than incremental test (6) due to the bioenergetics responses that are closer to the competitive events (5, 6) and the fact that athletes can freely manage the power output. Hence, cyclists tend to accept and engage more in time trial tests than in incremental ones (7). In addition, time trial performance variables (e.g. power output and time to complete the distance/work), ranging from three to 100 kilometers (6), have shown high correlations with aerobic endurance indices measured during incremental tests (8-10). Physiological parameters have often been recorded during time trials to evaluate acute responses and/or training effects (1, 10-13). Local and systemic training responses have been associated with increased aerobic endurance performance (14, 15). These training responses can be detected in physiological variables (e.g. heart rate and electromyography activity) over the season (1, 14-17). However, the accuracy of these variables to detect real training responses remains unknown, at least when time trials are used to evaluate athletes. The 40-km time trial has been considered the most reliable test among time trials (9, 11, 12, 18, 19). However, the 40-km time trial lasts nearly one hour (11, 12), whereas the five-kilometer time trial (TT5km) lasts from 7 to 12 minutes. The TT5km maintains the competition characteristics, such as prologue and short time trials (7, 20, 21), and its duration corresponds to the group of aerobic endurance tests (14, 21). This time trial has been used to assess aerobic endurance performance, to predict maximal lactate steady state intensity and 40-km time trial performance (5, 8, 18, 22-25). Then, the TT5km may be a better alternative to evaluate endurance fitness compared with the longer ones. Furthermore, the TT5km has been also used as performance test in guides for practical settings (26) and in research protocols (8, 16, 27), for instance, to evaluate the effect of arterial oxygen content on performance and peripheral quadriceps fatigue using electromyography (16). However, TT5km validation criteria have not been checked, in spite of its wide use. The TT5km absolute reliability was evaluated in two studies with reduced sample sizes (16, 24), whereas relative reliability has not been evaluated. Other studies have also correlated TT5km performance with aerobic endurance indices (18, 22, 23, 25); however, TT5km per se has received low importance in such studies, and the sensitivity of the test has not been evaluated. Only one of these studies has strictly aimed to validate the TT5km as the predictor of the maximal lactate steady state velocity (23). However, it has not evaluated important validation criteria (e.g. absolute and relative reliability, and sensitivity). Thus, the current literature has not consistently defined whether the TT5km can be used as a valid cycling test to evaluate aerobic endurance performance. Moreover, reference parameters to detect real significant changes in TT5km performance are important to the interpretation of test results (e.g. typical error and the smallest worthwhile change).

2. Objectives

The aim of this study was to perform a preliminary validation of the TT5km to 1) rank well-trained cyclists based on aerobic endurance fitness; 2) assess changes of the aerobic endurance performance.

3. Materials and Methods

3.1. Subjects

The volunteers were classified as well-trained cyclists according to previous literature criteria (21). Twenty well-trained male cyclists participated in this study (Table 1). All of them were involved in regional or national races. They were instructed to refrain from vigorous activities and ingestion of beverages containing alcohol or caffeine within 24 hours prior to each test. All tests were performed at the same time of day ([+ or -] 1 hour). Volunteers were informed about the experimental procedures and gave written informed consent. The study was approved by the local ethics committee.

3.2. Experimental Procedure

This is a cross-validation and test-retest design study determining the preliminary validity of TT5km. It was carried out in three sessions, an incremental test and two time trials. Each test used physiological (electromyography and heart rate) and performance variables (absolute and relative power output, time to complete and average speed) to determine the validation criteria: absolute and relative reliability; cross-validation in relation to incremental test; internal responsiveness evaluating the smallest worthwhile change and typical error relationship.

3.3. Incremental Test

In the first session, volunteers performed an incremental test (starting at 100 W + 50 W.2 [min.sup.-1]) until exhaustion (voluntary or cadence < 70 rpm) on the cycle simulator (Velotron Dynafit, Racer Mate[R], USA). Power output and heart rate were recorded during the entire test. Maximal aerobic power output and peak heart rate were determined, as well as these variables at the metabolic thresholds determined by heart rate variability method (28, 29). Peak heart rate was considered as the highest value in the last minute of incremental test, and it was used to normalize the heart rate data from subsequent tests in percentage. Maximal aerobic power output was considered as the highest power output maintained during the test, determined from the Equation 1 (10).

(1) MAP = Wfinal + (t/120 x 50)

Where, MAP is the maximal aerobic power output (W), Wfinal is the power output of the last completed stage, t is the duration of the uncompleted stage at exhaustion (s). Heart rate was recorded in beats per minutes and RR intervals in milliseconds using a portable monitor (RS800CX POLAR[R], Finland), validated for similar purposes to the present study (30). The heart rate variability method allowed detecting the first and second heart rate variability thresholds, corresponding to the ventilatory threshold and the respiratory compensation point (28), respectively. Other authors have named these points as aerobic and anaerobic thresholds (29).

3.4. Five-Kilometer Time Trial

In the 2nd and 3rd sessions, separated by at least two recovery days, each volunteer performed two TT5km on cycle simulator (TT5[km.sub.1], TT5[km.sub.2]). Before testing, the volunteers had performed a freely chosen light warm-up (~100W during 10 minutes), becoming familiar with the electronic gear ratios. The setup of cycle simulator was reproduced in both TT5km sessions for each athlete. After warming-up, the participants performed a torque-velocity test to normalize the quadriceps muscle electromyography (31) (see details in the Electromyography Activity section). Five minutes after torque-velocity test, the participants performed a standardized warm-up (consisting of 3 sets of 5 minutes at 70, 80, and 90% of power output corresponding to the first heart rate variability threshold) (32). After two minutes of rest, the TT5km was initiated. Figure 1 shows the protocol overview.

3.5. Electromyographic Activity

The electromyographic activity of the Quadriceps muscle (Rectus Femoris, Vastus Lateralis, and Vastus Medialis) from the right leg was recorded during the torque-velocity test and TT5km. The electrode sites were identified according to the SENIAM recommendations (34), marked with indelible ink and prepared by the same experimenter in both sessions.

Before placement of the electrodes (SOLIDOR[R], Medico Electrodes International, India; interelectrode distance = 20 mm), the skin was shaved, lightly rubbed with abrasive gel and cleaned with alcohol swabs. Electromyography signals were recorded using a portable telemetry device (TeleMyo DTS; Noraxon[R], AZ, USA; sampling rate at 2000 Hz, common-mode rejection rate at 95 dB, signal passing limit was [+ or -] 5 V). The raw electromyography signals were smoothed using a fourth-order band-pass Butterworth digital filter, with a frequency range set between 20 and 500 Hz, using a customized code (MathWorks[R], South Natick, MA, USA). The reference electrode was placed over the anterior iliac crest of the right side. The torque-velocity test performed before the TT5km consisted of two "all-out" sprints (8 s; workload at 7.5% body mass; rest interval of 5 minutes between the sprints). The average root mean square for each muscle was calculated every second from the 2nd till the end of torque-velocity test. The highest value between two torque-velocity tests was used to normalize the signals obtained during the TT5km (31). After the normalization, the quadriceps electromyography activity values were calculated as the average of root mean square normalized from three quadriceps muscles.

3.6. Statistical Analyses

The data are presented as mean and standard deviation (s). The Student's paired t-test was used to compare absolute and relative [5K.sub.PO], [5K.sub.AVS], [5K.sub.Time], average heart rate and quadriceps electromyography between TT5[km.sub.1] and TT5[km.sub.2]. Two-factor analysis of variance (ANOVA) for repeated measures (TT5km session vs. partial distances) was used to analyse the reliability of pacing strategy between both TT5km (interactive effect). When necessary, the Greenhouse-Geisser adjustment was used. The absolute reliability (agreement) was evaluated by the typical error obtained the Equation 2 (35):

(2) TE = [SD.sub.diff]/[square root of (2)]

where, TE is the typical error, [SD.sub.dff] is the standard deviation of the score differences from each volunteer between TT5[km.sub.1] and TT5[km.sub.2]. Typical error was also reported as a coefficient of variation in percentage (6). Relative reliability (consistency) was evaluated using the two-way mixed model intraclass correlation coefficient (3,1) for consistency (36) and its respective confidence interval (95% CI). Pearson's product-moment correlation coefficient and coefficient of determination were used to verify the concurrent validation between the aerobic endurance indices obtained from incremental test (maximal aerobic power output, and power output at the first and the second heart rate variability thresholds) and TT5km variables. When any TT5km variable had adequate consistency (intraclass coefficient [greater than or equal to] 0.90), the correlation was run. To evaluate the test sensitivity (2, 37) (i.e. internal responsiveness (36), the smallest worthwhile change was calculated to detect the minimal score to consider an important difference in TT5km performance. It was determined as 20% of between-subjects standard deviation (Cohen's effect size) (37), and calculated to TT5km variables that presented strong correlations ([greater than or equal to] 0.70) with the incremental test indices. Although the smallest worthwhile change obtained from the Cohen's effect size is suggested for team sports, it can be used for individual sports when real results of competitions are not available (36, 37). The sensitivity index was determined from the ratio of the smallest worthwhile change and typical error (2). Since a test is considered sensitive when the smallest worthwhile change is greater than typical error (37), the sensitivity index greater than one allows considering the test as sensitive. The significance level adopted was 5% (P < 0.05). All data was analysed using the software Microsoft Excel 2010 (Microsoft Corporation, WA, USA) and the statistical software SPSS 17.0 (SPSS, Inc.[R], Chicago, IL, USA).

4. Results

The power output and heart rate corresponding to the maximal aerobic power output, the first and the second heart rate variability thresholds are presented in Table 2.

The [5K.sub.Time] ranged from 425 to 576s (7 min: 05 s-9 min: 36 s). The TT5[km.sub.1] and TT5[km.sub.2] were significantly correlated regarding to the performance variables (Table 3). However, the absolute (t = 3.406; P < 0.05) and relative (t = 3.243; P < 0.05) [5K.sub.PO] of the TT5[km.sub.2] were greater than the ones of TT5[km.sub.1]. Consequently, the [5K.sub.Time] (t = 3.895; P < 0.05) and 5KAVS (t = 3.901; P < 0.05) were significantly different between the TT5km tests. Average heart rate of the TT5[km.sub.2] was significantly lower than at TT5[km.sub.1] (t = 6.980; P < 0.05). The average quadriceps electromyography did not differ between tests (n = 17; t = 0.130; P = 0.898).

Despite the differences in the average of performance variables, the pacing strategy did not differ significantly between TT5km tests to power output (F (3.03, 57.62) = 1.298; P = 0.284) and average speed (F (2.14, 40.71) = 0.298; P = 0.759). Heart rate (F (2.14, 40.71) = 0.298; P = 0.759) and RPE (F (4, 76) = 0.265; P = 0.900) serial responses to the pacing strategy were not significantly different between TT5km tests (interaction effect, Figure 2 and 3). Quadriceps electromyography serial responses showed significant difference between TT5[km.sub.1] and TT5[km.sub.2] (n = 17; F(2.07,33.13) = 6.485; P < 0.05) (interaction effect; Figure 2).

The absolute and relative reliability data are presented in Table 4. All TT5km performance variables presented high reliability due to the low coefficient of variation (power output < 3.4%; time to complete < 1.9%) and the high intraclass coefficient correlation (> 0.90), being adequate values for time trials (2). The average of heart rate presented good absolute reliability and poor relative reliability. The absolute and relative reliability of quadriceps electromyography average were low.

All TT5km performance variables presented strong correlations and high coefficient of determination with the aerobic endurance indices obtained from incremental test (Table 5). The correlations increased from the first to the second TT5km. Higher correlations ([greater than or equal to] 0.85) occurred with power output at the second heart rate variability threshold (Table 5).

The TT5km performance variables presented sensitivity to detect important changes in performance (sensitivity index > 1). Consequently, typical error was smaller than the smallest worthwhile change in every TT5km performance variable (Table 6).

5. Discussion

The aim of this study was to perform a preliminary validation of the TT5km to 1) assess changes of the aerobic endurance performance and 2) rank well-trained cyclists based on aerobic endurance fitness. The TT5km can rank the aerobic endurance fitness among well-trained cyclists due to the adequate absolute and relative reliability, as well as high correlation with aerobic endurance indices obtained from the incremental test. The TT5km can also differentiate the changes in aerobic endurance performance once the performance variables presented the smallest worthwhile change higher than typical error. When the performance variables were compared ([5K.sub.PO], [5K.sub.avs], [5K.sub.Time]), we found higher performance in the TT5[km.sub.2]. Although the sample comprised experienced athletes in road cycling, habituated to perform time trials, such differences may be related to the absence of a specific familiarization session. However, the pacing strategy between TT5km tests (interaction effect) was not significantly different from all variables, excepting for quadriceps electromyographic activity. Although the athletes predominantly increased their performance in the TT5[km.sub.2], they maintained their pacing strategy and rank position in the classification test. This information is supported by strong correlations between performance variables from the TT5[km.sub.1] and TT5[km.sub.2], and consistency of the relative reliability data. Thus, the consistency with the TT5[km.sub.2] showed that TT5[km.sub.1] could differentiate performance of the cyclists. Further, absolute reliability of performance indices was acceptable. These arguments emerge a critical problem around this point: familiarization sessions vs. available time for the assessments. Even the learning effect being known (2, 6, 11), multiple familiarization sessions are unfeasible in the practical environment. Thus, a test that has already presented reliability and high correlation between the two first sessions is a desirable option for practical purposes. Moreover, the TT5km presents these characteristics even when it is compared to 40-km time trial data (11, 12). However, despite the absolute reliability of the TT5km performance variables was compatible with other time trials (6, 11, 12), our results suggest that one familiarization session may be required, mainly when using the TT5km for the first time. More sessions are not required in theory because reliability studies using time trials have shown that performance between the second and subsequent sessions are reproduced adequately (6). The TT5km has the coaches' desirable characteristics (e.g. short duration, lower level of fatigue), even when the familiarization session is required. Moreover, for the subsequent re-evaluations, this familiarization session may not be required once time trials present good reliability even when repeated after a long time (13). The reliability of the TT5km performance variables is equivalent to or better than longer time trials in the literature (6, 11, 13, 35). Nonetheless, this observation was not consistently reproduced in the physiological variables. Although the heart rate had presented good absolute reliability, as described in other studies (12, 13), it presented poor relative reliability. These results demonstrate the inability to rank the athletes' responses using heart rate. We consider that the narrow range of intensities in which the TT5km is performed ([+ or -] 4% of heart rate at anaerobic threshold) harms the consistency, where small variations can significantly change the position of a volunteer in the ranking. The non-significant correlation between heart rate average of the TT5[km.sub.1] and the TT5[km.sub.2] reinforces this argument. Therefore, it is not recommended to use heart rate to detect differences in aerobic endurance performance. Similar recommendation has to be followed to quadriceps electromyography due to its low absolute reliability, although some studies have been using such variables to evaluate neuromuscular function during research protocols (15, 16) and training season (1, 17). Thus, heart rate and quadriceps electromyography do not seem to be reliable parameters to evaluate changes in aerobic endurance performance. physiological variables tend to show larger errors and they are not adequate to rank or predict changes in performance, at least when using time trials (19, 38). The correlation and the sensitivity index in the TT5km performance variables were evaluated due to their high reliability. The physiological and neuromuscular variables did not show good reliability, making no sense for their additional evaluations. Qur data presented strong correlations and shared variance between the TT5km performance variables and the aerobic endurance indices obtained from incremental test. The data are comparable with the correlations between the same indices and 40-km time trial performance indices (9, 11). Additionally, these aerobic endurance indices are considered performance predictors in several endurance sports (1, 7, 9, 10, 22). It is worth mentioning that the stronger correlations were between the 5Kpo (absolute and relative) and power output at the second heart rate variability threshold. This threshold is interpreted as the anaerobic threshold (29), and high indices elicited at this physiological marker (e.g. average speed or power output) are considered essential for a successful endurance performance (1, 7). Our performance data was better correlated with indices at the anaerobic threshold than 40-km time trial in a previous study (11). The majority of the inter-volunteers variation in [5K.sub.PO] during the TT5[km.sub.1] (74%) and the TT5[km.sub.2] performances (82%) is explained by the power output at the second heart rate variability threshold. Besides strong correlations with power output at anaerobic threshold, the TT5km has also shown strong correlation and shared variance with 40-km time trial performance (18, 22), which is considered a reliable time trial to evaluate aerobic endurance performance in the laboratory and field (11, 18, 19). The 40-km time trial has also been frequently used to predict intensity at the maximal lactate steady state (11, 18, 19). The TT5km has predicted the maximal lactate steady state and the 40-km time trial intensity (23). Our present results demonstrated that the TT5km distinguishes the athletes regarding to the aerobic endurance level similarly to the 40-km time trial. Then, these results suggest that the TT5km is valid to assess aerobic endurance performance in cyclists and to rank athletes regarding to their aerobic endurance fitness as well as incremental and 40-km time trial tests do. Thus, if the TT5km is able to detect the changes induced by longitudinal interventions, it has more advantages than incremental test and 40 km-time trial, which are: higher capacity to assess the inherent technical ability of the modality than incremental test (3, 9); the physiological demand and sensation more similar to real race than incremental test (5, 6); the capacity to predict the intensity corresponding to the 40km time trial and maximal lactate steady state more accurately than using incremental and constant load tests, performing a single session (18, 22, 23, 38); duration and fatigue level lesser than in the 40 km-time trial. Hence, TT5km sensitivity was also evaluated. The TT5km presented sensitivity index > 1 for all performance variables, showing its ability to detect longitudinal changes in the performance (internal responsiveness). The cross-sectional studies with experimental interventions corroborate with our sensitivity data. For instance, some studies have used the TT5km in their research protocols to evaluate performance (8, 16, 27). These studies have used interventions aiming to reduce the capacity of determinant systems for the aerobic endurance performance. Performing the TT5km, the performance (i.e. [5K.sub.PO] and [5K.sub.Time]) was greater and lower than our smallest worthwhile change values for effective (8, 16) and non-effective reduction of capacity in the systems (27), respectively. This information means that the smallest worthwhile change from our data could detect the effective and non-effective changes in aerobic endurance performance. Further, the estimated confidence interval for detecting the differences in performance presented in a previous study was similar to the smallest worthwhile change for [5K.sub.PO] and [5K.sub.Time] of our study (24). Then, these results suggest adequate sensitivity and validity of the TT5km to differentiate aerobic endurance performance in cyclists. However, a longitudinal study should verify whether the magnitude of changes in the TT5km performance caused by long-term training is higher than the smallest worthwhile change values, and closely related to aerobic endurance indices change (i.e. external responsiveness) (36). Moreover, although our sample comprised well-trained cyclists who had experience in time trials, the TT5km performance varied considerably between the best and worst athlete (e.g. almost equal to 2.5 minute). This range may have overestimated our relative reliability index, and future studies are needed to verify the relative reliability using elite cyclists. It is also, worth mentioning that the feedback of distance could have influenced the pacing strategy and learning effect. Although we cannot evaluate such influence in our study, feedback has not changed performance in short time trials similar to our protocol (39). From the results of this study, coaches can use the TT5km to differentiate performance and to rank athletes through simple and affordable parameters, without endangering subsequent training sessions. For instance, using the confidence interval of the smallest worthwhile changes from this study, an increment of 17.7 W in average power output allows detecting improvements in aerobic endurance performance. On the other hand, a similar amount of decrement after high training loads can suggest a functional overreaching. Similar rationale can be followed in relative power output ([+ or -] 0.3 W.[kg.sup.-1]), time to complete the test ([+ or -] 13.4 s), or average speed variables ([+ or -] 1.0 km.[h.sup.-1]). All of them are parameters provided by most of the cycle simulators and devices used to control training sessions. The TT5km is a valid test to rank the aerobic endurance fitness of well-trained cyclists and to differentiate changes on aerobic endurance performance. However, a familiarization session is recommended for the first time the test will be performed. A future study should investigate the longitudinal validity of the TT5km.

DOI: 10.5812/asjsm.23802

Published online 2015 September 28.


The authors would like to thank the members of the physiological adaptations to training research group (GEAFIT, Brazil), especially Marcelo Vitor da Costa and Henrique Bortolotti, for their time commitment and help during data collection of this study. We would like to thank Professor Leandro Ricardo Altimari for providing the support and suggestions during the study. The authors would like to thank the Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES) for graduate scholarships.


(1.) Lucia A, Hoyos J, Perez M, Chicharro JL. Heart rate and performance parameters in elite cyclists: a longitudinal study. Med Sci Sports Exerc. 2000; 32(10):1777-82.

(2.) Currell K, Jeukendrup AE. Validity, reliability and sensitivity of measures of sporting performance. Sports Med. 2008; 38(4):297-316.

(3.) Reilly T, Morris T, Whyte G. The specificity of training prescription and physiological assessment: a review. J Sports Sci. 2009; 27(6):575-89.

(4.) Bentley DJ, Newell J, Bishop D. Incremental exercise test design and analysis: implications for performance diagnostics in endurance athletes. Sports Med. 2007; 37(7):575-86.

(5.) Foster C, Green MA, Snyder AC, Thompson NN. Physiological responses during simulated competition. Med Sci Sports Exerc. 1993; 25(7):877-82.

(6.) Hopkins WG, Schabort EJ, Hawley JA Reliability of power in physical performance tests. Sports Med. 2001; 31(3):211-34.

(7.) Mujika I, Padilla S. Physiological and performance characteristics of male professional road cyclists. Sports Med. 2001; 31(7):479-87.

(8.) Amann M, Hopkins WG, Marcora SM. Similar sensitivity of time to exhaustion and time-trial time to changes in endurance. Med Sci Sports Exerc. 2008; 40(3):574-8.

(9.) Amann M, Subudhi AW, Walker J, Eisenman P, Shultz B, Foster C. An evaluation of the predictive validity and reliability of ventilatory threshold. Med Sci Sports Exerc. 2004; 36(10):1716-22.

(10.) Hawley JA, Noakes TD. Peak power output predicts maximal oxygen uptake and performance time in trained cyclists. Eur J Appl Physiol Occup Physiol. 1992; 65(1):79-83.

(11.) Laursen PB, Shing CM, Jenkins DG. Reproducibility of a laboratory-based 40-km cycle time-trial on a stationary wind-trainer in highly trained cyclists. Int J Sports Med. 2003; 24(7):481-5.

(12.) Smith MF, Davison RC, Balmer J, Bird SR. Reliability of mean power recorded during indoor and outdoor self-paced 40 km cycling time-trials. Int J Sports Med. 2001; 22(4):270-4.

(13.) Zavorsky GS, Murias JM, Gow J, Kim DJ, Poulin-Harnois C, Kubow S, et al. Laboratory 20-km cycle time trial reproducibility. Int J Sports Med. 2007; 28(9):743-8.

(14.) Jones AM, Carter H. The effect of endurance training on parameters of aerobic fitness. Sports Med. 2000; 29(6):373-86.

(15.) Lucia A, Pardo J, Durantez A, Hoyos J, Chicharro JL. Physiological differences between professional and elite road cyclists. Int J Sports Med. 1998; 19(5):342-8.

(16.) Amann M, Eldridge MW, Lovering AT, Stickland MK, Pegelow DF, Dempsey JA. Arterial oxygenation influences central motor output and exercise performance via effects on peripheral locomotor muscle fatigue in humans. J Physiol. 2006; 575(Pt 3):937-52.

(17.) Lucia A, Hoyos J, Pardo J, Chicharro JL. Metabolic and neuromuscular adaptations to endurance training in professional cyclists: a longitudinal study. Jpn J Physiol. 2000; 50(3):381-8.

(18.) Harnish CR, Swensen TC, Pate RR. Methods for estimating the maximal lactate steady state in trained cyclists. Med Sci Sports Exerc. 2001; 33(6):1052-5.

(19.) Paton CD, Hopkins WG. Tests of cycling performance. Sports Med. 2001; 31(7):489-96.

(20.) Earnest CP, Foster C, Hoyos J, Muniesa CA, Santalla A, Lucia A. Time trial exertion traits of cycling's Grand Tours. Int J Sports Med. 2009; 30(4):240-4.

(21.) Jeukendrup AE, Craig NP, Hawley JA. The bioenergetics of World Class Cycling. J Sci Med Sport. 2000; 3(4):414-33.

(22.) Amann M, Subudhi AW, Foster C. Predictive validity of ventilatory and lactate thresholds for cycling time trial performance. Scand J Med Sci Sports. 2006; 16(1):27-34.

(23.) Campbell CSG, Sousa WH, Ferreira JN, Assenco F, Simoes HG. Prediction of maximal lactate steady state velocity based on performance in a 5km cycling test. RevBraz Cineantropom Perform Hum. 2007; 9(3):223-30.

(24.) Jensen K, Johansen L. Reproducibility and validity of physiological parameters measured in cyclists riding on racing bikes placed on a stationary magnetic brake. Scand J Med Sci Sports. 1998; 8(1):1-6.

(25.) Swensen TC, Harnish CR, Beitman L, Keller BA Noninvasive estimation of the maximal lactate steady state in trained cyclists. Med Sci Sports Exerc. 1999; 31(5):742-6.

(26.) Armstrong L, Carmichael C, Nye PJ. The Lance Armstrong Performance Program: Seven Weeks to the Perfect Ride. Pennsylvania: Rodale; 2000.

(27.) Amann M, Proctor LT, Sebranek JJ, Pegelow DF, Dempsey JA. Opioid-mediated muscle afferents inhibit central motor drive and limit peripheral muscle fatigue development in humans. J Physiol. 2009; 587(Pt 1):271-83.

(28.) Cottin F, Lepretre PM, Lopes P, Papelier Y, Medigue C, Billat V Assessment of ventilatory thresholds from heart rate variability in well-trained subjects during cycling. Int J Sports Med. 2006; 27(12):959-67.

(29.) Di Michele R, Gatta G, Di Leo A, Cortesi M, Andina F, Tam E, et al. Estimation of the anaerobic threshold from heart rate variability in an incremental swimming test. J Strength Cond Res. 2012; 26(11):3059-66.

(30.) Gamelin FX, Berthoin S, Bosquet L. Validity of the polar S810 heart rate monitor to measure R-R intervals at rest. Med Sci Sports Exerc. 2006; 38(5):887-93.

(31.) Rouffet DM, Hautier CA. EMG normalization to study muscle activation in cycling.JElectromyogrKinesiol. 2008; 18(5):8 6 6-78.

(32.) Hajoglou A, Foster C, De Koning JJ, Lucia A, Kernozek TW, Porcari JP. Effect of warm-up on cycle time trial performance. Med Sci Sports Exerc. 2005; 37(9):1608-14.

(33.) Borg GA Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982; 14(5):377-81.

(34.) Hermens HJ, Freriks B, Disselhorst-Klug C, Rau G. Development of recommendations for SEMG sensors and sensor placement procedures. J Electromyogr Kinesiol. 2000; 10(5):361-74.

(35.) Hopkins WG. Measures of reliability in sports medicine and science. Sports Med. 2000; 30(1):1-15.

(36.) Impellizzeri FM, Marcora SM. Test validation in sport physiology: lessons learned from clinimetrics. Int J Sports Physiol Perform. 2009; 4(2):269-77.

(37.) Hopkins WG. How to interpret changes in an athletic performance test. Sport sci. 2004; 8:1-7.

(38.) Van Schuylenbergh R, Vanden Eynde B, Hespel P. Correlations between lactate and ventilatory thresholds and the maximal lactate steady state in elite cyclists. Int J Sports Med. 2004; 25(6):403-8.

(39.) Mauger AR, Jones AM, Williams CA. Influence of feedback and prior experience on pacing during a 4-km cycle time trial. Med Sci Sports Exerc. 2009; 41(2):451-8.

Jose Luiz Dantas, [1,2], * Gleber Pereira, [3,4] and Fabio Yuzo Nakamura [2]

[1] Department of Neurosciences and Imaging, Gabriele d'Annunzio University of Chieti-Pescara, Chieti, Italy

[2] Department of Physical Education, State University of Londrina, Londrina, Brazil

[3] Center for Biological and Health Sciences, University of Positivo, Curitiba, Brazil Department of Physical Education, Federal University of Parana, Curitiba, Brazil

* Corresponding author: Jose Luiz Dantas, Department of Neurosciences and Imaging, Gabriele d'Annunzio University of Chieti-Pescara, Chieti, Italy Tel: +39-8713554039, Fax: +39-8713554043, E-mail:

Received: November 20, 2013; Accepted: September 10, 2014

Table 1. Anthropometric and Training Background of the Cyclists

                        Values (a)        Minimal   Maximum

Weight, kg          69.8 [+ or -] 5.6      60.0      83.0
Height, m           1.75 [+ or -] 0.05     1.64      1.86
Age, y              31.3 [+ or -] 8.1      18.0      52.0
Body mass index,    22.7 [+ or -] 1.6      19.3      24.9
Training volume,   422.5 [+ or -] 156.8     200       800
Training             9.0 [+ or -] 7.4       1.0      30.0
  experience, y

(a) Values are presented as mean [+ or -] SD.

Table 2. Descriptive Data of the Indices Obtained
From Incremental Test (a,b)

                             Power Output

Indices            Absolute, W          Relative,

MAP            360.5 [+ or -] 49.5   5.2 [+ or -] 0.7
[HRV.sub.t1]   221.8 [+ or -] 49.6   3.2 [+ or -] 0.8
[HRV.sub.t2]   294.8 [+ or -] 46.5   4.2 [+ or -] 0.7

                          Heart Rate

Indices          Absolute,          Relative,
                    bpm          %[HR.sub.peak]

MAP            193 [+ or -] 8          --
[HRV.sub.t1]   156 [+ or -] 8   81.8 [+ or -] 4.2
[HRV.sub.t2]   172 [+ or -] 8   89.9 [+ or -] 3.7

(a) Abbreviations: %HRpeak, relative to heart rate peak;
[HRV.sub.T1], first heart rate variability thresholds; [HRV.sub.T2] =
second heart rate variability thresholds; and MAP, maximal aerobic
power output.

(b) All the indices are significantly different among them within
specific variable, P < 0.05.

Table 3. Descriptive Data of Indices Obtained
During Time Trial 5 Kilometers (a,b)

                          TT5[km.sub.1]           TT5[km.sub.2]

[5K.sub.PO], W         282.7 [+ or -] 53.5    291.7 [+ or -] 52.4 (d)
%MAP                    78.2 [+ or -] 8.5      80.7 [+ or -] 7.0
5KPO rel.,               4.1 [+ or -] 0.8       4.2 [+ or -] 0.8 (d)
5KTime, s              485.6 [+ or -] 40.5    477.6 [+ or -] 36.1 (e)
5kavs km.[h.sup.-1]     37.3 [+ or -] 3.0      37.9 [+ or -] 2.7 (e)
HR, %[HR.sub.peak]      93.3 [+ or -] 2.5      86.8 [+ or -] 3.8 (e)
qemg, %[RMS.sub.MAX]    39.2 [+ or -] 8.7      38.9 [+ or -] 9.5

                       r (c)   P Value

[5K.sub.PO], W         0.976   < 0.001
%MAP                    --       --
5KPO rel.,             0.970   < 0.001
5KTime, s              0.980   < 0.001
5kavs km.[h.sup.-1]    0.978   < 0.001
HR, %[HR.sub.peak]     0.223   > 0.05
qemg, %[RMS.sub.MAX]   0.505   < 0.05

(a) Abbreviations: %MAP, percentage of the maximal aerobic power
output; [5K.sub.AVS], average speed of TT5km; [5K.sub.PO], average
power output of TT5km; [5K.sub.PO] rel., ratio between [5K.sub.PO]
and body mass; [5K.sub.Time], time to complete TT5km; HR, heart rate;
[Q.sub.EMG], normalized Quadriceps electromyography activity;
TT5[km.sub.1], first time trial 5 kilometers ; and TT5[km.sub.1],
second time trial 5 kilometers.

(b) n = 17.

(c) Correlation coefficient.

(d) Significant difference in relation TT5[km.sub.1], P < 0.05.

(e) Significant difference in relation TT5[km.sub.1], P < 0.01.

Table 4. Reliability of the Performance and Physiological
Variables Obtained From TT5km Tests (a)

                     Absolute Reliability   Relative Reliability

Physiological        TE    CV, %    ICC       95%CI       P Value

[5K.sub.PO] W        8.2    2.9    0.976   0.940-0.990    < 0.001
5KPO rel.,           0.1    2.9    0.970   0.925-0.988    < 0.001
[5K.sub.Time], s     6.3    1.3    0.973   0.934-0.989    < 0.001
[5K.sub.AVS],        0.5    1.2    0.975   0.937-0.990    < 0.001
HR, %[HR.sub.peak]   2.9    3.2    0.206   -0.249-0.587   > 0.05
[Q.sub.EMG],         6.4   16.4    0.503   0.04 6-0.786   < 0.05

(a) Abbreviations: [5K.sub.PO], average power output of TT5km;
[5K.sub.PO] rel., ratio between 5KPO and body mass; [5K.sub.Time],
time to complete TT5km; [5K.sub.AVS], average speed of TT5km; 95%CI,
confidence interval of the ICC; CV, coefficient of variation; HR,
average heart rate of TT5km; ICC, intraclass coefficient correlation;
[Q.sub.emg], average of normalized Quadriceps electromyography
activity; and TE, typical error.

Table 5. Relationship Between Aerobic Endurance Indices Obtained From
Incremental Test and TT5km Variables Obtained From Both Time Trials


Variables                                   r     [R.sup.2]   P Value

[5K.sub.PO], W
  [5K.sub.PO] vs. MAP                      0.85      0.72      < 0.001
  [5K.sub.PO] vs. PO at [HRV.sub.T1]       0.77      0.59      < 0.001
  [5K.sub.PO] vs. PO at [HRV.sub.T2]       0.86      0.74      < 0.001
Relative [5K.sub.PO], Watts.[kg.sup.-1]
  [5K.sub.PO] rel. vs. MAP, W              0.84      0.71      < 0.001
  [5K.sub.PO] rel. vs. PO at               0.77      0.59      < 0.001
    [HRV.sub.T1], W
  [5K.sub.PO] rel. vs. PO at               0.86      0.74      < 0.001
    [HRV.sub.T2], W
[5K.sub.Time], s
  [5K.sub.Time] vs. MAP, W                -0.81     0.66      < 0.001
  [5K.sub.Time] vs. PO at                 -0.70     0.48      < 0.001
    [HRV.sub.T1], W
  [5K.sub.Time] vs. PO at                 -0.80     0.64      < 0.001
    [HRV.sub.T2], W
[5K.sub.AVS], km.[h.sup.-1]
  [5K.sub.AVS] vs. MAP, W                  0.83      0.68      < 0.001
  [5K.sub.AVS] vs. PO at                   0.72      0.52      < 0.001
    [HRV.sub.T1], W
  [5K.sub.AVS] vs. PO at                   0.83      0.69      < 0.001
    [HRV.sub.T2], W


Variables                                   r     [R.sup.2]   P Value

[5K.sub.PO], W
  [5K.sub.PO] vs. MAP                      0.90      0.81      < 0.001
  [5K.sub.PO] vs. PO at [HRV.sub.T1]       0.78      0.60      < 0.001
  [5K.sub.PO] vs. PO at [HRV.sub.T2]       0.91      0.82      < 0.001
Relative [5K.sub.PO], Watts.[kg.sup.-1]
  [5K.sub.PO] rel. vs. MAP, W              0.90      0.81      < 0.001
  [5K.sub.PO] rel. vs. PO at               0.77      0.59      < 0.001
    [HRV.sub.T1], W
  [5K.sub.PO] rel. vs. PO at               0.91      0.82      < 0.001
    [HRV.sub.T2], W
[5K.sub.Time], s
  [5K.sub.Time] vs. MAP, W                -0.87      0.75      < 0.001
  [5K.sub.Time] vs. PO at                 -0.72      0.52      < 0.001
    [HRV.sub.T1], W
  [5K.sub.Time] vs. PO at                 -0.84      0.71      < 0.001
    [HRV.sub.T2], W
[5K.sub.AVS], km.[h.sup.-1]
  [5K.sub.AVS] vs. MAP, W                  0.88      0.78      < 0.001
  [5K.sub.AVS] vs. PO at                   0.75      0.56      < 0.001
    [HRV.sub.T1], W
  [5K.sub.AVS] vs. PO at                   0.87      0.76      < 0.001
    [HRV.sub.T2], W

(a) Abbreviations: [5K.sub.PO], average power output of the entire
test; [5K.sub.PO] rel., ratio between [5K.sub.PO] and body mass;
[5K.sub.Time], time to complete TT5km; [5K.sub.AVS], average speed of
TT5km; [HRV.sub.T1], first heart rate variability threshold;
[HRV.sub.T2], second heart rate variability threshold; MAP, maximal
aerobic power output; PO, power output; r, Pearson's coefficient
correlation; [R.sup.2], coefficient of determination; TTS[km.sub.1],
first Time Trial 5 kilometers; and TT5[km.sub2], second Time Trial 5

Table 6. Sensitivity of the Performance Variables
Monitored During the TT5km (a)

                    TE        90%CI       SWC        90%CI        SI

[5K.sub.PO], W      8.2   [+ or -] 13.5   10.7   [+ or -] 17.7    1.3
[5K.sub.PO] rel.,   0.1   [+ or -] 0.2    0.2    [+ or -] 0.3     1.6
[5K.sub.Time], s    6.3   [+ or -] 10.4   8.1    [+ or -] 13.4    1.3
[5K.sub.AVS],       0.5   [+ or -] 0.8    0.6    [+ or -] 1.0     1.2

(a) Abbreviations: [5K.sub.PO], average power output of the entire
test; [5K.sub.PO] rel., ratio between [5K.sub.PO] and body mass;
[5K.sub.Time], time to complete TT5km; [5K.sub.AVS], average speed of
the entire test; 90%CI, confidence interval; CV, coefficient of
variation; SI, sensitivity index; SWC, the smallest worthwhile
change; and TE, typical error.
COPYRIGHT 2015 Tehran University of Medical Sciences
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Research Article
Author:Dantas, Jose Luiz; Pereira, Gleber; Nakamura, Fabio Yuzo
Publication:Asian Journal of Sports Medicine (AsJSM)
Date:Sep 1, 2015
Previous Article:Effects of a mask on breathing impairment during a fencing assault: a case series study.
Next Article:Effect of therapeutic sequence of hot pack and ultrasound on physiological response over trigger point of upper trapezius.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters